renal cancer
Asian Patients Should Get Lower Dose Of Kidney Cancer Drug
Singaporean mRCC patients could see a 30 percent reduction in their drug fees thanks to a lower dosing regiment.
3SBio To Develop DJ5 For Progressive Renal Failure
3SBio Inc. has acquired patents for DJ5 to develop DJ5 as a treatment for progressive renal failure in patients with autosomal dominant polycystic kidney disease.
Baxter China To Increase Rural Access To Renal Therapy
Baxter China has piloted a program to deploy a sustainable care and delivery model for peritoneal dialysis patients living in rural areas of the country.
SFJ Pharma To Conduct Phase III Trial Of Pfizer’s Axitinib Adjuvant Treatment In Asia
SFJ Pharma Ltd. will conduct a Phase III clinical trial in Asia of Pfizer's axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma following nephrectomy.
